CM Management, LLC
- SEC CIK
- 0001841857
- Latest filing
- Aug 13, 2026
NBSE holding history
NeuBase Therapeutics, Inc. in every 13F filed by CM Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NBSE overviewAll 13F holders of NBSEFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −6,000−100.0% | Sold out | Holders |
| Q2 2023 | 6,000 | $11.0K | <0.1% | 00.0% | UnchangedConverted for a 1-for-20 split | Holders |
| Q1 2023 | 120,000 | $22.0K | <0.1% | −230,000−65.7% | Reduced | Holders |
| Q4 2022 | 350,000 | $67.0K | 0.1% | −100,000−22.2% | Reduced | Holders |
| Q3 2022 | 450,000 | $178.0K | 0.2% | +80,000+21.6% | Added | Holders |
| Q2 2022 | 370,000 | $389.0K | 0.4% | +45,000+13.8% | Added | Holders |
| Q1 2022 | 325,000 | $611.0K | 0.5% | +175,000+116.7% | Added | Holders |
| Q4 2021 | 150,000 | $422.0K | 0.3% | +75,000+100.0% | Added | Holders |
| Q3 2021 | 75,000 | $271.0K | 0.2% | +75,000 | New | Holders |